Global Forensic Genomic Market Overview:
Global Forensic Genomic Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Forensic Genomic Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Forensic Genomic involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Forensic Genomic Market:
The Forensic Genomic Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Forensic Genomic Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Forensic Genomic Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Forensic Genomic market has been segmented into:
Blood
Saliva
Hair
Urine
Tissue
By Application, Forensic Genomic market has been segmented into:
Next-Generation Sequencing (NGS
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Forensic Genomic market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Forensic Genomic market.
Top Key Players Covered in Forensic Genomic market are:
QIAGEN
Illumina
FTDNA
PerkinElmer
Eurofins Scientific
Veritas Genetics
Myriad Genetics
Promega
Becton
Dickinson and Company
Thermo Fisher Scientific
Agilent Technologies
Invitae
Cegedim SR
DNASTAR
Oxford Nanopore Technologies
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Forensic Genomic Market Type
4.1 Forensic Genomic Market Snapshot and Growth Engine
4.2 Forensic Genomic Market Overview
4.3 Blood
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Blood: Geographic Segmentation Analysis
4.4 Saliva
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Saliva: Geographic Segmentation Analysis
4.5 Hair
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Hair: Geographic Segmentation Analysis
4.6 Urine
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Urine: Geographic Segmentation Analysis
4.7 Tissue
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Tissue: Geographic Segmentation Analysis
Chapter 5: Forensic Genomic Market Application
5.1 Forensic Genomic Market Snapshot and Growth Engine
5.2 Forensic Genomic Market Overview
5.3 Next-Generation Sequencing (NGS
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Next-Generation Sequencing (NGS: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Forensic Genomic Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 QIAGEN
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 ILLUMINA
6.4 FTDNA
6.5 PERKINELMER
6.6 EUROFINS SCIENTIFIC
6.7 VERITAS GENETICS
6.8 MYRIAD GENETICS
6.9 PROMEGA
6.10 BECTON
6.11 DICKINSON AND COMPANY
6.12 THERMO FISHER SCIENTIFIC
6.13 AGILENT TECHNOLOGIES
6.14 INVITAE
6.15 CEGEDIM SR
6.16 DNASTAR
6.17 OXFORD NANOPORE TECHNOLOGIES
Chapter 7: Global Forensic Genomic Market By Region
7.1 Overview
7.2. North America Forensic Genomic Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Blood
7.2.2.2 Saliva
7.2.2.3 Hair
7.2.2.4 Urine
7.2.2.5 Tissue
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Next-Generation Sequencing (NGS
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Forensic Genomic Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Blood
7.3.2.2 Saliva
7.3.2.3 Hair
7.3.2.4 Urine
7.3.2.5 Tissue
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Next-Generation Sequencing (NGS
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Forensic Genomic Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Blood
7.4.2.2 Saliva
7.4.2.3 Hair
7.4.2.4 Urine
7.4.2.5 Tissue
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Next-Generation Sequencing (NGS
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Forensic Genomic Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Blood
7.5.2.2 Saliva
7.5.2.3 Hair
7.5.2.4 Urine
7.5.2.5 Tissue
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Next-Generation Sequencing (NGS
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Forensic Genomic Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Blood
7.6.2.2 Saliva
7.6.2.3 Hair
7.6.2.4 Urine
7.6.2.5 Tissue
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Next-Generation Sequencing (NGS
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Forensic Genomic Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Blood
7.7.2.2 Saliva
7.7.2.3 Hair
7.7.2.4 Urine
7.7.2.5 Tissue
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Next-Generation Sequencing (NGS
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Forensic Genomic Scope:
|
Report Data
|
Forensic Genomic Market
|
|
Forensic Genomic Market Size in 2025
|
USD XX million
|
|
Forensic Genomic CAGR 2025 - 2032
|
XX%
|
|
Forensic Genomic Base Year
|
2024
|
|
Forensic Genomic Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
QIAGEN, Illumina, FTDNA, PerkinElmer, Eurofins Scientific, Veritas Genetics, Myriad Genetics, Promega, Becton, Dickinson and Company, Thermo Fisher Scientific, Agilent Technologies, Invitae, Cegedim SR, DNASTAR, Oxford Nanopore Technologies.
|
|
Key Segments
|
By Type
Blood
Saliva
Hair
Urine
Tissue
By Applications
Next-Generation Sequencing (NGS
|
